Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,699.38
(
1.01%
)
US TECH 100
23,950.80
(
-0.27%
)
Dow Jones
46,946.41
(
0.83%
)
Brent Oil
100.97
(
2.71%
)
Bitcoin
73,748.48
(
-1.46%
)
News Focus
News Focus
Post# of 257250
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122790
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: rwwine post# 112888

Thursday, 01/20/2011 2:03:35 PM

Thursday, January 20, 2011 2:03:35 PM

Post# of 257250
Absent any new information, I rate the cumulative probability of FDA approval of NVS/MNTA’s Copaxone ANDA by the end of 2011, 2012, 2013, and 2014, respectively, at 42%, 68%, 78%, and 84%. JMHO, FWIW

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now